Coagulation and fibrinolysis in amniotic fluid: Physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 2, 2011, Pages 165-174

  Uszyński, Mieczysław ^a   Uszyński, Waldemar ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Regional Hospital in Włocławek   (Poland)

Author keywords

Amniotic fluid; anticoagulants; fibrinolysis; procoagulants; PROM

Indexed keywords

PHOSPHATIDYLSERINE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOPLASTIN; UROKINASE; UROKINASE RECEPTOR;

AMNION FLUID; AMNION FLUID EMBOLISM; ARTICLE; BLOOD CLOTTING; DECIDUA; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HEMOSTASIS; PHYSIOLOGY; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL;

AMNIOTIC FLUID; BLOOD COAGULATION; EMBOLISM, AMNIOTIC FLUID; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; FIBRINOLYSIN; FIBRINOLYSIS; HUMANS; PHOSPHATIDYLSERINES; PRE-ECLAMPSIA; PREGNANCY; THROMBIN; THROMBOPLASTIN;

EID: 79952304553     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1270345     Document Type: Article

References (39)

1. Albrechtsen O K., Trolle D. A fibrinolytic system in human amniotic fluid. Acta Haematol 1955 14 6 376-382
2. Uszyski M, Maciejewski K, Uszyski W, Kuczyski J. Placenta and myometriumthe two main sources of fibrinolytic components during pregnancy. Gynecol Obstet Invest 2001 52 3 189-193
3. Lockwood C J., Krikun G, Rahman M, Caze R, Buchwalder L, Schatz F. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin Thromb Hemost 2007 33 1 111-117 (Pubitemid 46184038)
4. Watanabe T, Araki M, Mimuro J, Tamada T, Sakata Y. Fibrinolytic components in fetal membranes and amniotic fluid. Am J Obstet Gynecol 1993 168 4 1283-1289 (Pubitemid 23122181)
5. Gulbis B, Jauniaux E, Jurkovic D, Thiry P, Campbell S, Ooms H A. Determination of protein pattern in embryonic cavities of human early pregnancies: a means to understand materno-embryonic exchanges. Hum Reprod 1992 7 6 886-889
6. Michel P E., Crettaz D, Morier P et al. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 2006 27 5-6 1169-1181
7. Mavrou A, Anagnostopoulos A K., Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses. J Proteome Res 2008 7 5 1862-1866
8. Tisi D K., Emard J J., Koski K G. Total protein concentration in human amniotic fluid is negatively associated with infant birth weight. J Nutr 2004 134 7 1754-1758 (Pubitemid 38886565)
9. Cade J F., Hirsh J, Martin M. Placental barrier to coagulation factors: its relevance to the coagulation defect at birth and to haemorrhage in the newborn. BMJ 1969 2 5652 281-283
10. Brace R A. Physiology of amniotic fluid volume regulation. In: Rao K A. Ross M G. eds. Amniotic Fluid. Bangalore, India Prism Books 1999 110-132
11. Köttgen E, Hell B, Müller C, Tauber R. Demonstration of glycosylation variants of human fibrinogen, using the new technique of glycoprotein lectin immunosorbent assay (GLIA). Biol Chem Hoppe Seyler 1988 369 10 1157-1166
12. Kimball M E., Milunsky A, Giannusa P, Carvalho A C. Amniotic fluid fibrinogen degradation products in the prenatal diagnosis of neural tube defects. Am J Obstet Gynecol 1977 128 3 294-299 (Pubitemid 8128934)
13. Lockwood C J., Bach R, Guha A, Zhou X D., Miller W A., Nemerson Y. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 1991 165 5 Pt 1 1335-1341
14. Erez O, Gotsch F, Mazaki-Tovi S et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med 2009 22 8 672-687
15. Uszyski M, ekanowska E, Uszyski W, Kuczyski J. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 2001 95 2 163-166 (Pubitemid 32297709)
16. González-Quintero V H., Jiménez J J., Jy W et al. Elevated plasma endothelial microparticles in preeclampsia. Am J Obstet Gynecol 2003 189 2 589-593
17. Thompson A R. Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis. Blood 1984 64 4 867-874 (Pubitemid 14003609)
18. Ludwig H, Metzger H. Das uterine Placentarbett post partum in Rasterelektronenmikroskop, zugleich ein Beitrag zur Frage der extravasalen Fibrinbildung. Arch Gynakol 1971 210 251-266
19. McVey J H. Tissue factor pathway. Baillieres Clin Haematol 1999 12 361-372 (Pubitemid 30312616)
20. Zhou J, Liu S, Ma M et al. Procoagulant activity and phosphatidylserine of amniotic fluid cells. Thromb Haemost 2009 101 5 845-851
21. Steiner P E., Lushbaugh C C. Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 1941 117 1245-1254
22. Uszyski W, Uszyski M, Zekanowska E. Thrombin markers in pregnant women: measurements of prothrombin fragments F 1 + 2 and thrombin-antithrombin III complexes (TAT) in the cord blood, the mother's blood and in amniotic fluid. [in Polish] Ginekol Pol 2004 75 8 595-602
23. Uszyski M, Zekanowska E, Kotzbach M, Uszyski W, Kotzbach R. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study. J Perinat Med 2006 34 4 289-292 (Pubitemid 44114565)
24. Uszyski W, Zekanowska E, Uszyski M, Rystok D. Concentration of annezin in gestational tissues: placenta, fetal membranes, myometrium, and amniotic fluid. [in Polish] Gin Pol 2006 77 603-610
25. Uszyski M, Kyszejko A, Zekanowska E. Plasminogen, (2)-antiplasmin and complexes of plasmin-(2)-antiplasmin (PAP) in amniotic fluid and blood plasma of parturient women. Eur J Obstet Gynecol Reprod Biol 2000 93 2 167-171
26. Uszyski M, Perlik M, Uszyski W, Zekanowska E. Urokinase plasminogen activator (uPA) and its receptor (uPAR) in gestational tissues; measurements and clinical implications. Eur J Obstet Gynecol Reprod Biol 2004 114 1 54-58 (Pubitemid 38507684)
27. Hajjar K A. Cellular receptors in the regulation of plasmin generation. Thromb Haemost 1995 74 1 294-301
28. Uszyski W, Uszyski M, Zekanowska E. Thrombin activatable fibrinolysis inhibitor (TAFI) in human amniotic fluid. A preliminary study. Thromb Res 2007 119 2 241-245 (Pubitemid 44802798)
29. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997 78 1 386-391 (Pubitemid 27289272)
30. Wang W, Boffa M B., Bajzar L, Walker J B., Nesheim M E. A study of the mechanism of fibrynolysis by activated thrombin-activatable inhibitor. J Biol Chem 1998 273 27176-27181 (Pubitemid 28500426)
31. Gris J C., Neveu S, Tailland M L., Courtieu C, Marès P, Schved J F. Use of a low-molecular weight heparin (enoxaparin) or of a phenformin-like substance (moroxydine chloride) in primary early recurrent aborters with an impaired fibrinolytic capacity. Thromb Haemost 1995 73 3 362-367
32. Vassalli J D. The urokinase receptor. Fibrinolysis 1994 8 172-181
33. Vadillo-Ortega F, Hernandez A, Gonzalez-Avila G, Bermejo L, Iwata K, Strauss JF III. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996 174 4 1371-1376 (Pubitemid 26131163)
34. Lijnen H R. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001 86 1 324-333 (Pubitemid 32663963)
35. Erez O, Espinoza J, Chaiworapongsa T et al. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor. J Matern Fetal Neonatal Med 2008 21 10 732-744
36. Stephenson C D., Lockwood C J., Ma Y, Guller S. Thrombin-dependent regulation of matrix metalloproteinase (MMP)-9 levels in human fetal membranes. J Matern Fetal Neonatal Med 2005 18 1 17-22 (Pubitemid 41224358)
37. Adachi T, Nakabayashi M, Sakwra M, Ando K. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia. Semin Thromb Hemost 1999 25 5 447-450 (Pubitemid 30010798)
38. Tanjung M, Siddik H Z., Hariman H et al. Coagulation and fibrinolysis in preeclampsia and neometes. Clin Appl Thromb/Hemost 2005 11 4 467-473
39. Hathaway W, Corrigan J. Report of Scientific and Standardization Subcommitee on Neonatal Hemostasis. Thromb Haemost 1991 65 323-325